Document Detail

Tranexamic Acid: a new option for heavy menstrual bleeding.
MedLine Citation:
PMID:  22900772     Owner:  NLM     Status:  In-Data-Review    
Heavy menstrual bleeding, or menorrhagia, af ects approximately one-third of women. Treatments have included nonsteroidal anti-inflammatories and oral contraceptives, although neither is approved by the Food and Drug Administration (FDA) specifically for this use. Lysteda® (tranexamic acid) has recently been approved as a treatment for heavy menstrual bleeding. This article gives a background on menorrhagia and describes treatment with tranexamic acid, including its implications for nurses.
Jeanne M Wilton
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nursing for women's health     Volume:  16     ISSN:  1751-486X     ISO Abbreviation:  Nurs Womens Health     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-08-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101304602     Medline TA:  Nurs Womens Health     Country:  United States    
Other Details:
Languages:  eng     Pagination:  146-50     Citation Subset:  N    
Copyright Information:
© 2012 AWHONN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early term birth: understanding the health risks to infants.
Next Document:  Using Smart Pumps to Reduce Medication Errors in the NICU.